Trinseo (TSE) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual General Meeting scheduled for June 25, 2025, with voting open until June 23, 2025.
Shareholders can access proxy materials online or request paper/email copies by June 11, 2025.
Meeting will be held in Dublin, Ireland, with in-person and online voting options.
Voting matters and shareholder proposals
Election of nine directors, each for a one-year term expiring at the 2026 Annual General Meeting.
Advisory vote to approve executive compensation for named executive officers.
Ratification of PricewaterhouseCoopers LLP as independent auditor for 2025 and authorization for the Audit Committee to set remuneration.
Proposal to grant the Board authority to issue shares under Irish law.
Proposal to allow the Board to opt out of statutory pre-emption rights for up to 10% of issued share capital.
Setting the price range for re-issuance of treasury shares.
Amendments to the 2014 Omnibus Incentive Plan.
Allowing CEO, CFO, and CLO to voluntarily forfeit stock options for no consideration, returning them to the equity plan.
Board of directors and corporate governance
Nine director nominees listed for election, each to serve a one-year term.
Latest events from Trinseo
- Q4 saw a $251M net loss, 19% sales drop, flat EBITDA, and ongoing restructuring challenges.TSE
Q4 202513 Mar 2026 - Q2 2024 Adjusted EBITDA hit a two-year high, with positive free cash flow expected in H2.TSE
Q2 20242 Feb 2026 - Q3 net loss of $87M, but Adjusted EBITDA rose $25M; liquidity and restructuring improved outlook.TSE
Q3 202415 Jan 2026 - Q4 2024 delivered higher EBITDA and cash flow, but losses persist amid weak demand and restructuring.TSE
Q4 20242 Dec 2025 - Shareholders will vote on directors, compensation, auditor, share issuance, and plan amendments.TSE
Proxy Filing1 Dec 2025 - Shareholders will vote on directors, executive pay, auditor, share issuance, and incentive plan changes.TSE
Proxy Filing1 Dec 2025 - Q2 2025 net loss and sales decline persist, but cost actions and liquidity measures support outlook.TSE
Q2 202524 Nov 2025 - Adjusted EBITDA rose to $65M in Q1 2025, driven by licensing income and cost savings.TSE
Q1 202522 Nov 2025 - Q3 2025 net loss widened to $110 million on 14% lower sales, with major restructuring underway.TSE
Q3 202514 Nov 2025